NEJM Group
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
NEJM Group
Jun 22, 2024, 15:13 |
Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
May 23, 2024, 14:31 |
Blog
Raja-Elie Abdulnour: RAG improves a GPT copilot in oncology guidelines questions
Raja-Elie Abdulnour, Editor, Clinical Development and AI Innovation at NEJM Group, posted on X: "RAG…
May 1, 2024, 00:59 |
Insight
Angela Mastronuzzi: Yet another impactful and giant step in clinical research
Angela Mastronuzzi shared on LinkedIn: "Also out with The NEW ENGLAND JOURNAL of MEDICINE of the NEJM Group:…
Mar 19, 2024, 20:14 |
Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 8, 2024, 19:12 |
Drugs
Naveen Pemmaraju: Rusfertide for patients with phlebotomy-dependent Polycythemia Vera (PV)
Naveen Pemmaraju posted on LinkedIn: ''Honored to share our brand new paper recently published in…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube